Cardiometabolic
Heart-healthy eating is becoming a health-system issue, not just a patient choice
A new American College of Cardiology scientific statement argues that cardiovascular nutrition should be judged by the quality of the overall dietary pattern, not isolated nutrients or macronutrient ratios.
Novo’s $1.4B Orbis Deal Bets on a New Route to Oral Cardiometabolic Drugs
Not All Fat Is Obesity: Lipedema Trial Challenges Weight-Centred Care
GLP-1s Are Winning on Weight. Muscle Is Becoming the Next Clinical Question
University students moved less than adults in their 70s. Cardiometabolic prevention may be starting too late
Obesity treatment is becoming a portfolio, not a product. Lilly’s EASD lineup shows what comes next
10,000 steps is not the only route to lower cardiovascular risk. Walking pace may matter too
Same BMI, different biology: low-cost markers may expose the obesity risk the scale misses
Cardiometabolic risk leaves a protein signature in childhood. Could it guide prevention decades earlier?
Obesity drugs may move beyond appetite suppression. Moonwalk just raised $70 million to target fat tissue directly
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
Diseases in Cardiometabolic
Explore disease data and country profiles on the IPM Alliance platform.
Explore diseases